BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brandt AS, Kukuk S, Dreger NM, Müller E, Roth S. Diagnostik und Therapie der retroperitonealen Fibrose. Urologe 2016;55:732-40. [DOI: 10.1007/s00120-016-0081-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Dreger NM, Degener S, Roth S, Ahmad-Nejad P, Kamper L, Müller E, von Rundstedt FC, Brandt AS. Impact of CYP2D6 Polymorphisms on Tamoxifen Treatment in Patients With Retroperitoneal Fibrosis: A First Step Towards Tailored Therapy? Urology 2020;137:84-90. [PMID: 31877313 DOI: 10.1016/j.urology.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Moll FH, Leissner J, Halling T. ["We're going to place a ureteral stent …" : Development and use of the terms stent and splint by German-speaking urologists]. Urologe A 2018;57:836-45. [PMID: 29946936 DOI: 10.1007/s00120-018-0693-4] [Reference Citation Analysis]
3 Brandt AS, Dreger NM, Müller E, Kukuk S, Roth S. Neue (und alte) Aspekte der retroperitonealen Fibrose. Urologe 2017;56:887-94. [DOI: 10.1007/s00120-017-0428-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]